BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

675 related articles for article (PubMed ID: 19955043)

  • 1. Serum BLC/CXCL13 concentrations and renal expression of CXCL13/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis.
    Lee HT; Shiao YM; Wu TH; Chen WS; Hsu YH; Tsai SF; Tsai CY
    J Rheumatol; 2010 Jan; 37(1):45-52. PubMed ID: 19955043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated production of serum B-cell-attracting chemokine-1 (BCA-1/CXCL13) is correlated with childhood-onset lupus disease activity, severity, and renal involvement.
    Ezzat M; El-Gammasy T; Shaheen K; Shokr E
    Lupus; 2011 Jul; 20(8):845-54. PubMed ID: 21576203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-cell-attracting chemokine CXCL13 as a marker of disease activity and renal involvement in systemic lupus erythematosus (SLE).
    Schiffer L; Kümpers P; Davalos-Misslitz AM; Haubitz M; Haller H; Anders HJ; Witte T; Schiffer M
    Nephrol Dial Transplant; 2009 Dec; 24(12):3708-12. PubMed ID: 19602475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective accumulation of CCR4+ T lymphocytes into renal tissue of patients with lupus nephritis.
    Yamada M; Yagita H; Inoue H; Takanashi T; Matsuda H; Munechika E; Kanamaru Y; Shirato I; Tomino Y; Matushima K; Okumura K; Hashimoto H
    Arthritis Rheum; 2002 Mar; 46(3):735-40. PubMed ID: 11920409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosus.
    Henneken M; Dörner T; Burmester GR; Berek C
    Arthritis Res Ther; 2005; 7(5):R1001-13. PubMed ID: 16207316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
    Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral circulating activated b-cell populations are associated with nephritis and disease activity in patients with systemic lupus erythematosus.
    Dolff S; Wilde B; Patschan S; Dürig J; Specker C; Philipp T; Kribben A; Witzke O
    Scand J Immunol; 2007 Nov; 66(5):584-90. PubMed ID: 17868260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated production of B cell chemokine CXCL13 is correlated with systemic lupus erythematosus disease activity.
    Wong CK; Wong PT; Tam LS; Li EK; Chen DP; Lam CW
    J Clin Immunol; 2010 Jan; 30(1):45-52. PubMed ID: 19774453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression and clinical significance of inducible co-stimulator on peripheral blood T lymphocyte subsets in patients with systemic lupus erythematosus].
    Yang JH; Shen Q; Zhao DB; Cai Q; Han XH
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):318-23. PubMed ID: 15854508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of chemokine receptors, CXCR4 and CXCR5, and chemokines, BLC and SDF-1, in the eyes of patients with primary intraocular lymphoma.
    Chan CC; Shen D; Hackett JJ; Buggage RR; Tuaillon N
    Ophthalmology; 2003 Feb; 110(2):421-6. PubMed ID: 12578791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PEG10 activation by co-stimulation of CXCR5 and CCR7 essentially contributes to resistance to apoptosis in CD19+CD34+ B cells from patients with B cell lineage acute and chronic lymphocytic leukemia.
    Hu C; Xiong J; Zhang L; Huang B; Zhang Q; Li Q; Yang M; Wu Y; Wu Q; Shen Q; Gao Q; Zhang K; Sun Z; Liu J; Jin Y; Tan J
    Cell Mol Immunol; 2004 Aug; 1(4):280-94. PubMed ID: 16225771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type I and II interferons commit to abnormal expression of chemokine receptor on B cells in patients with systemic lupus erythematosus.
    Yoshikawa M; Nakayamada S; Kubo S; Nawata A; Kitanaga Y; Iwata S; Sakata K; Ma X; Wang SP; Nakano K; Saito K; Tanaka Y
    Clin Immunol; 2019 Mar; 200():1-9. PubMed ID: 30576845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential control of CD22 ligand expression on B and T lymphocytes, and enhanced expression in murine systemic lupus.
    Lajaunias F; Ida A; Kikuchi S; Fossati-Jimack L; Martinez-Soria E; Moll T; Law CL; Izui S
    Arthritis Rheum; 2003 Jun; 48(6):1612-21. PubMed ID: 12794829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus.
    Feng X; Wu H; Grossman JM; Hanvivadhanakul P; FitzGerald JD; Park GS; Dong X; Chen W; Kim MH; Weng HH; Furst DE; Gorn A; McMahon M; Taylor M; Brahn E; Hahn BH; Tsao BP
    Arthritis Rheum; 2006 Sep; 54(9):2951-62. PubMed ID: 16947629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenetic role of glomerular CXCL13 expression in lupus nephritis.
    Worthmann K; Gueler F; von Vietinghoff S; Davalos-Mißlitz A; Wiehler F; Davidson A; Witte T; Haller H; Schiffer M; Falk CS; Schiffer L
    Clin Exp Immunol; 2014 Oct; 178(1):20-7. PubMed ID: 24827905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-155 Suppresses Mesangial Cell Proliferation and TGF-β1 Production via Inhibiting CXCR5-ERK Signaling Pathway in Lupus Nephritis.
    Kong J; Li L; Lu Z; Song J; Yan J; Yang J; Gu Z; Da Z
    Inflammation; 2019 Feb; 42(1):255-263. PubMed ID: 30209639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal expression of galectin-3 in systemic lupus erythematosus patients with nephritis.
    Kang EH; Moon KC; Lee EY; Lee YJ; Lee EB; Ahn C; Song YW
    Lupus; 2009 Jan; 18(1):22-8. PubMed ID: 19074165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum level of selected chemokines in systemic lupus erythematosus patients taking into consideration the peripheral blood leukocyte counts].
    Kopczyńska M; Franek A; Błaszczak E; Dworak J; Kopczyński P; Hrycek A
    Pol Merkur Lekarski; 2013 May; 34(203):251-4. PubMed ID: 23894774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD134 expression on CD4+ T cells is associated with nephritis and disease activity in patients with systemic lupus erythematosus.
    Patschan S; Dolff S; Kribben A; Dürig J; Patschan D; Wilde B; Specker C; Philipp T; Witzke O
    Clin Exp Immunol; 2006 Aug; 145(2):235-42. PubMed ID: 16879242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.